跳至主要内容
临床试验/NCT06230081
NCT06230081
进行中(未招募)
不适用

Postoperative Analgesia in Patients Undergoing Hip and Knee Replacement Surgery - a Study Comparing Ultrasound-guided Nerve Blocks With Intraoperative Local Anesthetic Infiltration or Opioids

Region Skane1 个研究点 分布在 1 个国家目标入组 400 人2024年2月1日

概览

阶段
不适用
干预措施
Ropivacain 5 mg/ml + Clonidine
疾病 / 适应症
Osteoarthritis of the Knee or Hip
发起方
Region Skane
入组人数
400
试验地点
1
主要终点
Difference in Postoperative pain assessed by NRS
状态
进行中(未招募)
最后更新
4天前

概览

简要总结

The purpose of this study is to evaluate the effect on postoperative pain, opioid consumption and function by adding a combination of regional blocks with local anaesthetic before total hip- and knee arthroplasty compared to standard pain management strategies.

详细描述

400 patients with osteoarthritis of the knee (200) or hip (200) necessitating total hip- or knee replacement are entered into the study. All patients are given a standard protocol of analgesics pre- and postoperatively. Patients are receiving general- or spinal anaesthesia during the surgery. General anaesthesia is conducted using Remifentanil 50ug/ml and Propofol 20 mg/ml utilizing a TCI protocol. The airway is managed by LMA or endotracheal tube. Spinal anaesthesia is conducted using isobaric Bupivacaine (hip) and hyperbaric bupivacaine (knee). Decision regarding type of anaesthesia is following guidelines of our department taking contraindications and patients preference into account. Patients randomized to the block-group undergoing hip replacement surgery with posterior approach are given och combination of PENG block and Iliohypogastric block using Ropivacain 5 mg/ml with a total dose of 200 mg along with clonidine in a total dose of 75 micrograms. Patients undergoing hip replacement with lateral approach are given a combination of PENG block and LFCN block using Ropivacain 5 mg/ml with a total dose of 125 mg along with clonidine in a total dose of 56,25 micrograms. Patients randomized to the standard pain management strategy undergoing hip replacement surgery are given a combination of opioids, paracetamol and Cox-II inhibitors. Patients randomized to the block-group undergoing knee replacement surgery are given a combination of iPACK-, genicular-, AFCN-, adductor canal and vastus intermedius block using Ropivacain 5 mg/ml with a total dose of 225 mg along with clonidine in a total dose of 75 micrograms. Patients randomized to the standard pain management strategy undergoing knee replacement surgery are given a perioperative periarticular LIA using Ropivacaine 300 mg along with 0,5 mg of adrenaline. The randomization is executed on the day before surgery by opening of a closed numbered envelope giving information if the specific patient should have a block (intervention) or not (control). There are 200 prepared envelopes for the hip replacements and 200 for the knee replacements, with 100 blocks and 100 no blocks for each type. The envelopes are prepared by block randomization performed by computer software. Nurses and physiotherapists who evaluate postoperative pain are blinded from the intervention. The physician compiling the data from the study is also blinded to the intervention. Preoperatively, information is collected regarding doses of analgesics and pain in everyday life is evaluated using the NRS scale. Preoperative pain is evaluated at rest and during mobilization. Postoperatively, an evaluation of pain is made. After the operation the patients are monitored at the ward by the nurses and physiotherapists. The registration takes place using the subjective Numeric Rating Scale (NRS) and the objective Critical-Care Pain Observation Tool (CPOT). Pain is continuously evaluated during the hospital stay. The final registration takes place at the return visit 14 days after surgery. During the hospital stay, other parameters such as opioid consumption, requirement for urinary catheter, postoperative nausea and vomiting (PONV), time to mobilization and neurological complications are also registered. The number of extra opioid doses the patient requires are also registered. The number of days the patients need to stay in hospital after surgery are registered.

注册库
clinicaltrials.gov
开始日期
2024年2月1日
结束日期
2026年4月26日
最后更新
4天前
研究类型
Interventional
研究设计
Parallel
性别
All

研究者

发起方
Region Skane
责任方
Sponsor

入排标准

入选标准

  • Osteoarthritis of the knee- or hip necessitating total knee- or hip replacement
  • Patients who understand the conditions of the study and are willing to participate for the length of the prescribed follow-up

排除标准

  • Known allergy to local anesthetics or other contraindication for the use of local anesthetics.
  • Coagulopathy
  • Bilateral operation
  • Revision arthroplasty

研究组 & 干预措施

Block

Hip Arthroplasty: Multimodal analgesic therapy + Ultrasound guided PENG block and Iliohypogastric block or LFCN-block. Knee arthroplasty: Multimodal analgesic therapy + Ultrasound guided iPACK block, triple Genicular blocks, Vastus intermedius block, Adductor canal block and AFCN-block.

干预措施: Ropivacain 5 mg/ml + Clonidine

No block

Hip Arthroplasty: Multimodal analgesic therapy Knee Arthroplasty: Multimodal analgesic therapy + LIA

结局指标

主要结局

Difference in Postoperative pain assessed by NRS

时间窗: The day of surgery, postop day 1 and 14 days post-surgery

Patient experienced postop pain assessed by NRS (0-10)

次要结局

  • urine catheter usage(1-5 days post-surgery)
  • Difference in analgesia consumption(The day of surgery, postop day 1 and 14 days post-surgery)
  • Time to mobilization(The day of surgery, postop day 1)
  • Incidence of postoperative nausea and vomiting(The day of surgery, postop day 1)
  • Difference in postoperative pain depending on method of anesthesia(The day of surgery, postop day 1 and 14 days post-surgery)
  • neurological complications(The day of surgery, postop day 1 and 14 days post-surgery)
  • Days in hospital(1-5 days post-surgery)
  • opioid consumption 14 days(14 days post-surgery)

研究点 (1)

Loading locations...

相似试验